Investors Land AKBA 5.5% Lower Than Its Secondary Stock Offering
May 13, 2020 at 10:05 AM EDT
Looking back to 2 days ago, Akebia Therapeutics Inc (AKBA) priced a 11,000,000 share secondary stock offering at $12.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..